Swapnil Bhargava
Chief Technical OfficerMr. Swapnil Bhargava, Ph.D. is Chief Technical Officer of CG Oncology, Inc. from September 2023. He was Senior Vice President of CMC Development & GMP Manufacturing of AbCellera Biologics Inc until 2023. He was responsible for building process development, MSAT, manufacturing, and supporting CMC capabilities to deliver optimal therapeutic antibodies from discovery to the clinic. Before joining AbCellera, he worked at Seagen as VP for drug substance process development, where he was responsible for leading cell line development, upstream and downstream, conjugation and analytical sciences departments. Prior to Seagen, he worked at Amgen leading process development efforts for different modalities, including biosimilars. He has supported multiple INDs and BLAs and has contributed to bringing multiple modalities to clinic and market. He has a BS and MS from the Indian Institute of Technology (IIT) Delhi. He completed Ph.D. from University of Maryland Baltimore Country in Chemical Engineering.
Positions
- Company NameCG Oncology, Inc.Stock CodeCGONPositionChief Technical OfficerColleagues
- AKArthur KuanPresident, Chairman & CEO
- JMJames M. DeToreChief Financial Officer
- JFJoshua F. PattersonGeneral Counsel, Chief Compliance Officer & Secretary
- VKVijay KasturiChief Medical Officer
- LELeonard E. PostLead Independent Director
- VEVictor E. TongIndependent Director
- SESusan E. GrafIndependent Director
- JJJames J. MuleIndependent Director
